-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AG6WyPlFwXRwW49GNCFENDRVHHtzD0JcrT33nn4xpACiAFdgeEgym8zYwiZiC63e riNjVPspDB05H1LdNM6d2A== 0001104659-10-026098.txt : 20100506 0001104659-10-026098.hdr.sgml : 20100506 20100506104003 ACCESSION NUMBER: 0001104659-10-026098 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100420 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20100506 DATE AS OF CHANGE: 20100506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMPHENOL CORP /DE/ CENTRAL INDEX KEY: 0000820313 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC CONNECTORS [3678] IRS NUMBER: 222785165 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10879 FILM NUMBER: 10804515 BUSINESS ADDRESS: STREET 1: 358 HALL AVE CITY: WALLINGFORD STATE: CT ZIP: 06492 BUSINESS PHONE: 2032658900 8-K/A 1 a10-9509_18ka.htm 8-K/A

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) April 20, 2010

 

AMPHENOL CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

 

1-10879

 

22-2785165

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

358 Hall Avenue, Wallingford, Connecticut

 

06492

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code (203) 265-8900

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 2.02 Results of Operations and Financial Condition

 

This Form 8-K/A amends the Form 8-K filed by Amphenol Corporation on April 20, 2010 to amend certain line items on the condensed consolidated statements of cash flow in connection with the adoption of Accounting Standards Update (“ASU”) No. 2009-16, Accounting for Transfers of Financial Assets. The Company adopted ASU 2009-16 on January 1, 2010.  As a result, transfers of receivables occurring on or after January 1, 2010 are reflected as debt issued in the Company’s Condensed Consolidated Statements of Cash Flow (resulting in a reduction of cash flows provided by operating activities of $82 million for the quarter ended March 31, 2010).  The resulting changes made to the line items on the condensed consolidated statements of cash flow to properly present the adoption of ASU 2009-16 are as follows.

 

1.                                       In the text of the press release the sentence on page 2 that reads “Cash flow from operations remained strong in the quarter at $114 million” has been changed to “Cash flow from operations (excluding a reduction of $82 million resulting from the adoption of a new accounting pronouncement) remained strong in the quarter at $114 million”;

 

2.                                       A caption has been added entitled “Net change in receivables sold under the Receivables Securitization Facility”.  For the three months ended March 31, 2010 and 2009, the related cash flows were $(82,000) and $6,000, respectively;

 

3.                                       For the three months ended March 31, 2009, the “Net change in components of working capital” has been changed from $40,255 to $34,255;

 

4.                                       For the three months ended March 31, 2010, the “Cash flow provided by operating activities” has been changed from $113,843 to $31,843;

 

5.                                       For the three months ended March 31, 2010, the “Net change in borrowings under the Receivables Securitization Facility” has been changed from $(33,000) to $49,000;

 

6.                                       For the three months ended March 31, 2010, the “Cash flow (used in) provided by financing activities” has been changed from $(33,280) to $48,720.

 

A copy of the amended condensed consolidated statements of cash flow, as well as, the condensed consolidated statements of income, condensed consolidated balance sheets, and segment information is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

Statements in this Form 8-K which are other than historical facts are intended to be “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, the Private Securities Litigation Reform Act of 1995 and other related laws.  While the Company believes such statements are reasonable, the actual results and effects could differ materially from those currently anticipated.  Please refer to Part I, Item 1A of the Company’s Form 10-K for the year ended December 31, 2009, for some factors that could cause the actual results to differ from estimates.  In providing forward-looking statements, the Company is not undertaking any duty or

 

2



 

obligation to update these statements publicly as a result of new information, future events or otherwise.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit 99.1                               Amended condensed consolidated statements of cash flow, condensed consolidated statements of income, condensed consolidated balance sheets, and segment information.

 

3



 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

AMPHENOL CORPORATION

 

 

 

By

/s/ Diana Reardon

 

 

Diana G. Reardon

 

 

Senior Vice President and Chief Financial Officer

 

 

Date: May 6, 2010

 

4


EX-99.1 2 a10-9509_1ex99d1.htm EX-99.1

EXHIBIT 99.1

 

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(dollars in thousands, except per share data)

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2010

 

2009

 

 

 

 

 

 

 

Net Sales

 

$

770,954

 

$

660,012

 

 

 

 

 

 

 

Cost of sales

 

521,762

 

453,633

 

 

 

 

 

 

 

Gross profit

 

249,192

 

206,379

 

 

 

 

 

 

 

Selling, general and administrative expense

 

104,148

 

95,694

 

 

 

 

 

 

 

Operating income

 

145,044

 

110,685

 

 

 

 

 

 

 

Interest expense

 

(10,013

)

(8,998

)

Other income (expenses), net

 

459

 

(215

)

 

 

 

 

 

 

Income before income taxes

 

135,490

 

101,472

 

 

 

 

 

 

 

Provision for income taxes

 

(35,352

)

(24,422

)

 

 

 

 

 

 

Net income

 

100,138

 

77,050

 

Less: Net income attributable to noncontrolling interests

 

(1,785

)

(2,640

)

 

 

 

 

 

 

Net income attributable to Amphenol Corporation

 

$

98,353

 

$

74,410

 

 

 

 

 

 

 

Net income per common share - Basic

 

$

0.57

 

$

0.43

 

 

 

 

 

 

 

Weighted average common shares outstanding - Basic

 

173,266,113

 

171,185,198

 

 

 

 

 

 

 

Net income per common share - Diluted

 

$

0.56

 

$

0.43

 

 

 

 

 

 

 

Weighted average common shares outstanding - Diluted

 

175,575,002

 

173,098,475

 

 

 

 

 

 

 

Dividends declared per common share

 

$

0.015

 

$

0.015

 

 



 

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(dollars in thousands)

 

 

 

March 31,

 

December 31,

 

 

 

2010

 

2009

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash and cash equivalents

 

$

431,719

 

$

384,613

 

Accounts receivable, less allowance for doubtful accounts of $18,022 and $18,785, respectively

 

572,616

(1)

449,591

 

Inventories, net

 

476,097

 

461,750

 

Other current assets

 

135,913

 

124,441

 

 

 

 

 

 

 

Total current assets

 

1,616,345

 

1,420,395

 

 

 

 

 

 

 

Land and depreciable assets, less accumulated depreciation of $572,922 and $575,187, respectively

 

327,211

 

332,875

 

Goodwill

 

1,371,800

 

1,368,672

 

Other long-term assets

 

95,160

 

97,242

 

 

 

 

 

 

 

 

 

$

3,410,516

 

$

3,219,184

 

 

 

 

 

 

 

LIABILITIES & SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

Accounts payable

 

$

319,820

 

$

292,122

 

Accrued salaries, wages and employee benefits

 

64,045

 

64,143

 

Accrued income taxes

 

70,117

 

57,272

 

Accrued acquisition-related obligations

 

5,744

 

7,244

 

Other accrued expenses

 

83,715

 

81,979

 

Short-term debt

 

49,440

(1)

399

 

 

 

 

 

 

 

Total current liabilities

 

592,881

 

503,159

 

 

 

 

 

 

 

Long-term debt

 

752,543

 

753,050

 

Accrued pension and post employment benefit obligations

 

171,082

 

172,235

 

Other long-term liabilities

 

26,569

 

27,922

 

 

 

 

 

 

 

Shareholders’ Equity:

 

 

 

 

 

Common stock

 

174

 

174

 

Additional paid-in capital

 

80,398

 

71,368

 

Accumulated earnings

 

1,870,378

 

1,774,625

 

Accumulated other comprehensive loss

 

(100,989

)

(100,090

)

 

 

 

 

 

 

Total shareholders’ equity attributable to Amphenol Corporation

 

1,849,961

 

1,746,077

 

 

 

 

 

 

 

Noncontrolling interests

 

17,480

 

16,741

 

 

 

 

 

 

 

Total equity

 

1,867,441

 

1,762,818

 

 

 

 

 

 

 

 

 

$

3,410,516

 

$

3,219,184

 

 


NOTE 1           The Company has a $100 million receivables securitization program.  In accordance with previous accounting guidance, this facility was accounted for off balance sheet as a sale of receivables.  Effective January 1, 2010, the Company adopted the amendments to the Transfers and Servicing and Consolidation Topics of the Accounting Standards Codification. The adoption of these amendments has resulted in the Company reporting transactions under this facility as short-term debt and the related receivables remain on the balance sheet.  At March 31, 2010, borrowings under the securitization facility were $49 million.

 



 

AMPHENOL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited)

(dollars in thousands)

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2010

 

2009

 

 

 

 

 

 

 

Cash flow from operating activities:

 

 

 

 

 

Net income

 

$

100,138

 

$

77,050

 

Adjustments for cash flow from operating activities:

 

 

 

 

 

Depreciation and amortization

 

24,344

 

22,991

 

Net change in receivables sold under Receivables Securitization Facility

 

(82,000

)(1)

6,000

 

Stock-based compensation expense

 

5,443

 

4,784

 

Net change in components of working capital

 

(15,286

)

34,255

 

Net change in other long-term assets and liabilities

 

(796

)

(2,315

)

 

 

 

 

 

 

Cash flow provided by operating activities

 

31,843

 

142,765

 

 

 

 

 

 

 

Cash flow from investing activities:

 

 

 

 

 

Additions to property, plant and equipment, net

 

(18,353

)

(16,871

)

(Purchase) sale of short term investments

 

(8,353

)

1,420

 

Acquisitions, net of cash acquired

 

(3,000

)

(261,464

)

 

 

 

 

 

 

Cash flow used in investing activities

 

(29,706

)

(276,915

)

 

 

 

 

 

 

Cash flow from financing activities:

 

 

 

 

 

Borrowings under revolving credit facilities

 

19,600

 

268,587

 

Payments under revolving credit facilities

 

(19,994

)

(182,700

)

Net change in borrowings under Receivables Securitization Facility

 

49,000

(1)

 

Proceeds from exercise of stock options

 

3,173

 

224

 

Excess tax benefits from stock-based payment arrangements

 

582

 

107

 

Payments to shareholders of noncontrolling interests

 

(1,046

)

 

Dividend payments

 

(2,595

)

(5,135

)

 

 

 

 

 

 

Cash flow provided by financing activities

 

48,720

 

81,083

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

(3,751

)

(11,401

)

 

 

 

 

 

 

Net change in cash and cash equivalents

 

47,106

 

(64,468

)

Cash and cash equivalents balance, beginning of period

 

384,613

 

214,987

 

 

 

 

 

 

 

Cash and cash equivalents balance, end of period

 

$

431,719

 

$

150,519

 

 


NOTE 1           The Company has a $100 million receivables securitization program.  In accordance with previous accounting guidance, this facility was accounted for off balance sheet as a sale of receivables.  Effective January 1, 2010, the Company adopted the amendments to the Transfers and Servicing and Consolidation Topics of the Accounting Standards Codification. As a result of the adoption transfers of receivables occurring on or after January 1, 2010 are reflected as debt issued in the Company’s Condensed Consolidated Statements of Cash Flow (resulting in a reduction of cash flows provided by operating activities of $82 million for the quarter ended March 31, 2010).

 



 

AMPHENOL CORPORATION

SEGMENT INFORMATION

(dollars in thousands)

(Unaudited)

 

 

 

Three months ended

 

 

 

March 31,

 

 

 

2010

 

2009

 

 

 

 

 

 

 

Trade Sales:

 

 

 

 

 

Interconnect Products

 

$

703,598

 

$

601,958

 

Cable Products

 

67,356

 

58,054

 

Consolidated

 

$

770,954

 

$

660,012

 

 

 

 

 

 

 

Operating income:

 

 

 

 

 

Interconnect Products

 

$

148,662

 

$

116,443

 

Cable Products

 

10,043

 

7,836

 

Stock-based compensation expense

 

(5,443

)

(4,784

)

Other operating expenses

 

(8,218

)

(8,810

)

Consolidated

 

$

145,044

 

$

110,685

 

 

 

 

 

 

 

ROS%:

 

 

 

 

 

Interconnect Products

 

21.1

%

19.3

%

Cable Products

 

14.9

%

13.5

%

Corporate - stock-based compensation

 

-0.7

%

-0.7

%

Corporate - all other

 

-1.1

%

-1.3

%

 

 

 

 

 

 

Consolidated

 

18.8

%

16.8

%

 


-----END PRIVACY-ENHANCED MESSAGE-----